Chapter
ADVANTAGES OF DNA MARKERS
MARKER ASSISTED SELECTION
MARKER ASSISTED BREEDING METHODS
QUANTITATIVE TRAIT LOCI (QTL) AND MAS
WEAKNESS/SHORTCOMING OF MAS
MAS AND INTELLECTUAL RIGHTS
CHAPTER 3.
METABOLOMICS - THE TECHNOLOGY OF THE FUTURE
DEVELOPMENT OF METABOLOMICS
COMPARISON WITH TRANSCRIPTOMICS AND PROTEOMICS
APPLICATIONS OF METABOLOMICS
[A] Environmental and Eco-Metabolomics
[B] Metabolomics and Crop Improvement
Future of Metabolomics in Crop Improvement
[C] Metabolomics and Human Health
[D] Metabolomics and Cancer
[E] Metabolomics in Drug Development
BIOINFORMATICS AND METABOLOMICS
CHAPTER 4.
PROTEOMICS: PRINCIPLES, CHALLENGES AND APPLICATIONS
THE NEED FOR PROTEOMIC ANALYSIS
ADVANTAGES OF PROTEOMIC STUDIES
TECHNIQUES EMPLOYED TO STUDY PROTEINS
APPLICATIONS OF PROTEOMICS
[A] Application in Environmental Sciences
[B] Proteomics in Disease Diagnostics and Drug Discovery
Proteomics and Biomarkers
Proteomics in Cancer Research
[C] Proteomics in Crop Improvement
[D] Proteomics in Food Science and Technology
BIOINFORMATICS AND PROTEOMICS
CHAPTER 5.
THE AGE OF POLYMER THERAPEUTICS
CONVENTIONAL DRUG DELIVERY
POLYMERS IN DRUG DELIVERY
[B] Polymer-Drug Conjugates
[C] Polymer-Protein Conjugates
[E] Multi-Component Polyplexes
CHAPTER 6.
NANOMEDICINE: THE NEXT GENERATION MEDICINE
HISTORY OF NANOTECHNOLOGY
NANOSCALE PARTICLES IN NANOMEDICINE
[C] Quantum Dots and Cornell Dots
[D] Dendrimers and Diamondoids
[E] Magnetic Nanoparticles
[F] Gold Nanoparticles (AuNP)
[G] Solid Lipid Nanoparticles (SLN)
[H] Polymeric Nanoparticles
[I] Ceramic Nanoparticles
APPLICATIONS ON NANOMEDICINE IN HEALTH SECTOR
[C] Tissue Implants and Tissue Engineering
[D] Targeted Drug Delivery and Therapy
SAFETY ASPECTS OF NANOMEDICINE
CHAPTER 7.
CISGENESIS AND INTRAGENESIS
CLASSICAL/CONVENTIONAL PLANT BREEDING
CISGENESIS AND INTRAGENESIS
ADVANTAGES OF CISGENESIS OVER CONVENTIONAL BREEDING AND TRANSGENESIS
DRAWBACKS AND LIMITATIONS OF CISGENESIS
(I) Random Insertion Site of the Gene
(II) Mutation Caused in the Plant Genome
APPLICATIONS OF CISGENESIS
GM REGULATIONS AND CISGENESIS
SAFETY ASPECT OF CISGENIC CROPS
CHAPTER 8.
GENETICALLY MODIFIED CROPS AND ALLERGENICITY: MYTH OR REALITY
ADVANTAGES OF GENETICALLY MODIFIED CROPS
SAFETY OF GENETICALLY MODIFIED CROPS
NEED FOR SAFETY EVALUATION OF GM FOODS
GENETICALLY MODIFIED FOODS AND ALLERGY
ASSESSMENT OF ALLERGENIC POTENTIAL OF GENETICALLY MODIFIED FOODS
GM CROPS AND ALLERGENICITY: CASE STUDIES AND RELATED CONTROVERSIES
SHEDDING THE NEGATIVE APPROACH
CHAPTER 9.
GENETICALLY MODIFIED CROPS-ARE WE ENGINEERING DESTRUCTION?
ADVANTAGES OF GM CROPS/FOODS
[A] Increased Nutritional Content
[B] Increasing Food Production
[C] Resistance to Abiotic Stresses
[D] Resistance to Insect Pests, Diseases and Herbicides
[A] Threat to Soil Fertility
[B] Gene Transfer and Super Weeds
[D] Risk to Other Life Forms
[E] Effects on Biodiversity
[F] Insect Resistant Crops
CHAPTER 10.
PHARMACOGENOMICS
PHARMACOGENETICS, PHARMACOGENOMICS AND PHARMACOTHERAPY
CONVENTIONAL DRUG DEVELOPMENT
ADVERSE DRUG REACTION [ADR]
HISTORY OF PHARMACOGENOMICS
TOOLS USED IN PHARMACOGENOMICS
PHARMACOGENOMICS AND PERSONALIZED MEDICINE
CURRENT APPLICATIONS OF PHARMACOGENOMICS
PHARMACEUTICAL INDUSTRY AND PHARMACOGENOMICS
LIMITATIONS AND RISKS OF PHARMACOGENOMICS
[A] Change in the Concept and Treatment of Disease
ETHICAL, SOCIAL AND LEGAL IMPLICATIONS
[A] Regulation of Pharmacogenomics
[C] Commercial Exploitation and IntellectualProperty of Pharmacogenetics Databanks
CHAPTER 11.
FUNCTIONAL FOODS AND NUTRACEUTICALS
WHAT ARE NUTRACEUTICALS AND FUNCTIONAL FOODS?
HISTORICAL EVOLUTION OF MEDICINAL NUTRIENTS
PLANTS AS FUNCTIONAL FOODS
ECOLOGICAL PERSPECTIVES OF FUNCTIONAL FOODS
BIOTECHNOLOGY AND FUNCTIONAL FOODS
[A] Improvement in Fatty Acid Profile
[B] Improvement in Protein Quality and Quantity
[C] Improvement in Vitamin Content
[D] Improvement in Carbohydrate
REASONS FOR GROWING INTEREST IN FUNCTIONAL FOODS AND NUTRACEUTICALS
REGULATION AND MARKETING OF NUTRACEUTICALS AND FUNCTIONAL FOODS
NUTRACEUTICALS AND NANOTECHNOLOGY
DEMAND FOR NUTRACEUTICALS
ETHICS IN FUNCTIONAL FOODS AND NUTRACEUTICALS
(i) Are Functional Foods Safe?
(ii) Are Functional Foods Effective?
(iii) Reliability and Trustworthiness of the Claims
(iv) Are Functional Foods Affordable to the Common Man?
(v) Socio-Cultural Dimension of Functional Foods
OPPORTUNITIES AND CHALLENGES
CHAPTER 12.
PLANT MOLECULAR FARMING
HISTORY OF PLANT MOLECULAR FARMING
USE OF PLANTS AS PRODUCTION SYSTEMS
METHODS OF GENE TRANSFER TO PLANTS
[A] Stable Nuclear Transformation
[B] Plastid Transformation
[C] Transient Expression Using Viral Vectors
PLANT SYSTEMS USED AS EXPRESSION PLATFORMS
TYPES OF PHARMACEUTICAL COMPOUNDS
(I) Plant Derived Human and Animal Vaccines
(II) Plant Derived Antibodies
(III) Pharmaceutical Proteins
(IV) Industrial Enzymes and other Molecules
(V) Plant Derived Secondary Metabolites
CONSTRAINTS IN PLANT SYSTEM
(I) High Cost of Downstream Processing
(II) Low Yield of Foreign Protein
COST EVALUATION OF RECOMBINANT BIOPHARMACEUTICALS
REGULATION FOR PRODUCTION OF PHARMACEUTICAL CROPS